Aflac Stock – Fundamental Analysis

Price
118.21
10/14/2026
Oct 1996
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 3/10/2026)

Balance Sheet Total Assets 116,470,000,000.00 ROE 25.32 %
Balance Sheet Total Equity 29,490,000,000.00 ROA 3.13 %
Cashflow Capital Expenditures -1.00 P/FCF 24.61
Cashflow Free Cash Flow 2,555,000,064.00 – –
Cashflow Operating Cash Flow 2,555,000,000.00 P/CF 24.61
Income Earnings per Share (diluted) 6.85 Div. Yield 1.96 %
Income Net Income 3,646,000,000.00 P/E 17.26
Income Shares Outstanding 532,015,000.00 P/B 2.13
Income Total Revenue 17,438,000,000.00 P/S 3.61

Ratios calculated on: 10/14/2026

Company Description

Aflac Incorporated (Aflac) is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services. Its business is supplemental health and life insurance, through its subsidiary, American Family Life Assurance Company of Columbus, which operates in the United States and as a branch in Japan. Aflac's insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells voluntary supplemental insurance products including loss-of-income products and products designed to protect individuals from depletion of assets (hospital indemnity, fixed-benefit dental, vision care, accident, cancer, critical illness/ critical care, and hospital intensive care plans).

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.aflac.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more